Fortune |
Boston biotech Intarcia raises major funding for type 2 diabetes …
The Boston Globe The Boston company raised $215 million in new investment as it works on a drug-device combination to treat diabetes. Diabetes 'Unicorn' Raises Final VC Round Before IPO – FortuneFortune Intarcia raises 1st chunk of planned $600M toward FDA OK of type …San Francisco Business Times (blog) all 7 news articles » |
More details can be found at www.diabeteshowto.com




Discussion
Comments are disallowed for this post.
Comments are closed.